Antiplatelet therapy for patients with COVID-19: Systematic review and meta-analysis of observational studies and randomized controlled trials

BACKGROUND: Hyperinflammation and coagulopathy are hallmarks of COVID-19 and synergistically contribute to illness progression. Antiplatelet agents have been proposed as candidate drugs for COVID-19 treatment on the basis of their antithrombotic and anti-inflammatory properties. A systematic review...

Descripción completa

Detalles Bibliográficos
Autores principales: Zong, Xiaolong, Wang, Xiao, Liu, Yaru, Li, Zhenyu, Wang, Weiding, Wei, Dianjun, Chen, Zhuqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490267/
https://www.ncbi.nlm.nih.gov/pubmed/36160149
http://dx.doi.org/10.3389/fmed.2022.965790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490267/
https://www.ncbi.nlm.nih.gov/pubmed/36160149
http://dx.doi.org/10.3389/fmed.2022.965790

Ejemplares similares